ArticleBlood advances2023
Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL.
Open access · goldAbstract read
In one paragraph
Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Systematic literature review to identify prognostic factors of efficacy and safety outcomes of chimeric antigen receptor T-Cell therapies in diffuse large B-Cell lymphoma.Journal of cancer research and clinical oncology · 2025Pooled it
- Decade-long persistence of CD19 CAR T cells in B cell lymphomas.Nature medicine · 2026Trial
- Remodeling memory T cells with chemotherapy and immune checkpoint inhibitors as host pre-conditioning to empower in vivo CAR-T therapy.Synthetic and systems biotechnology · 2026Review
- A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.Bone marrow transplantation · 2026Article
- CAR-T cells and CAR-Treg cells for treatment of inflammatory bowel diseases.EULAR rheumatology open · 2026Review
- Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design.CPT: pharmacometrics & systems pharmacology · 2026Article
- Article
- Machine Learning-Assisted Rapid Optical Imaging for Label-Free CAR T-Cell Detection in Whole Blood.Biosensors · 2026Article
- Development of a flow cytometry method to measure antidrug antibodies against CAR T cells.ImmunoHorizons · 2026Article
- Article
- CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.Blood advances · 2026Article
- Universal high-sensitivity CAR T-cell monitoring by targeting linker sequences.Frontiers in immunology · 2026Article
- International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.Blood advances · 2025Article
- Routine Monitoring of CAR-T-Cells Expansion and Persistence in Patients With Aggressive Large B-Cell Lymphoma by Flow Cytometry: A Single-Center Experience.Hematological oncology · 2025Article
- Blood proteomics for quantitative biomarkers of cellular therapies.Biomarker research · 2025Review
- Current Insights of Post-Infusion CAR T Expansion and Persistence for Large B-Cell Lymphoma.Cancers · 2025Review
- Article
- Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphoma.HemaSphere · 2025Article
- Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells.HemaSphere · 2024Article
- CAR T-cell expansion: harmful or helpful?Blood advances · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors at 5 institutions in 2 countries.
Viktoria BlumenbergDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-1379-0876
Galina BuschLaboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany.
Stephan BaumannLaboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany.ORCID 0009-0001-2804-2072
Regina JitschinDepartment of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Gloria IacoboniDepartment of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0003-0805-9288
Laura GallurDepartment of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0001-6293-9281
Josu Iraola-TruchueloDepartment of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID 0000-0002-9909-3715
Eva HosterDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-0749-1389
Michael WinkelmannDepartment of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
Konstantin HellwigDepartment of Radiology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.ORCID 0000-0001-9001-2176
Christian SchmidtDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
Lisa FrölichDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
Benjamin TastLaboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany.
Friederike HildebrandDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
Kai RejeskiDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
Franziska DekorsyDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Christian SchmidkonzBavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.
Tobias BäuerleDepartment of Radiology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Wolfgang G KunzDepartment of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-5021-1952
Dimitrios MougiakakosDepartment of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.ORCID 0000-0002-2817-6660
Fabian MüllerDepartment of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.ORCID 0000-0001-5487-5839
Michael von Bergwelt-BaildonDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
Pere BarbaDepartment of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Veit L BückleinDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-7391-7280
Andreas MackensenDepartment of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.ORCID 0000-0002-0685-4483
Simon VölklDepartment of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
Marion SubkleweDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-3905-0251
LMU Klinikum · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DELudwig-Maximilians-Universität München · DEUniversitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Receptors, Antigen, T-CellT-LymphocytesFlow CytometryReceptors, Antigen, T-Cell
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.